Literature DB >> 26198661

Two Patients With Visual Aura - Migraine, Epilepsy, or Migralepsy?

Elisabeth Hartl1, Jan Rémi1, Soheyl Noachtar1.   

Abstract

BACKGROUND: The concept of migralepsy refers to visual migraine auras that seemingly evolve into epileptic seizures. It was discussed controversially ever since and scientific proof for this entity is scarce.
METHODS: We report two patients with visual aura fulfilling the diagnostic criteria for migralepsy. In both patients, habitual attacks were recorded during long-term video electroencephalography (EEG) monitoring. CASE
RESULTS: Both patients demonstrated unilateral occipital EEG seizure patterns during their long-lasting visual aura, which eventually evolved into versive seizures.
CONCLUSION: Here, we prove the epileptic origin of the visual auras, which have been misdiagnosed as migraine or migralepsy before. Additional evaluation should be considered in patients with visual aura and hints for an epileptic origin as occipital lobe epilepsy might be missed in patients diagnosed with migraine. Based on our patients, we suggest to challenge the concept of migralepsy in current classifications.
© 2015 American Headache Society.

Entities:  

Keywords:  epilepsy; migraine; migralepsy; visual aura

Mesh:

Year:  2015        PMID: 26198661     DOI: 10.1111/head.12615

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  3 in total

Review 1.  The complex interrelations between two paroxysmal disorders: headache and epilepsy.

Authors:  Carlo Cianchetti; Giuliano Avanzini; Filippo Dainese; Vincenzo Guidetti
Journal:  Neurol Sci       Date:  2017-03-24       Impact factor: 3.307

Review 2.  [Diagnosis of non-epileptic paroxysmal disorders and epileptic seizures].

Authors:  S Noachtar; B Güldiken
Journal:  Nervenarzt       Date:  2017-10       Impact factor: 1.214

Review 3.  Headache in people with epilepsy.

Authors:  Prisca R Bauer; Else A Tolner; Mark R Keezer; Michel D Ferrari; Josemir W Sander
Journal:  Nat Rev Neurol       Date:  2021-07-26       Impact factor: 42.937

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.